-
psnet.ahrq.gov/node/50417/psn-pdf
September 04, 2019 - communicating-uncertainty-narrative-review-and-framework-future-research
Uncertainty in care delivery is rarely discussed
-
psnet.ahrq.gov/node/851201/psn-pdf
July 05, 2023 - Lack of timely diagnosis is a major consideration discussed.
-
psnet.ahrq.gov/node/853628/psn-pdf
September 20, 2023 - of the peers who knew of the situation
and were not psychologically safe enough to report it, are discussed
-
psnet.ahrq.gov/node/48050/psn-pdf
June 05, 2019 - A past
PSNet interview discussed the OpenNotes project.
-
psnet.ahrq.gov/node/50419/psn-pdf
September 04, 2019 - A WebM&M commentary
discussed an incident involving an elderly patient who experienced an adverse drug
-
psnet.ahrq.gov/node/50585/psn-pdf
October 30, 2019 - Speakers at the webinar
discussed what’s different and what to expect when transitioning to the revised
-
psnet.ahrq.gov/node/60196/psn-pdf
April 01, 2020 - This news story discussed the
shortage of protective masks for pharmacists and the potential unintended
-
psnet.ahrq.gov/node/838255/psn-pdf
October 05, 2022 - Speakers participating in this webinar discussed the impact of errors on families, adverse event
prevalence
-
psnet.ahrq.gov/node/866905/psn-pdf
October 09, 2024 - dual-process-models-clinical-reasoning-central-role-knowledge-diagnostic-
expertise
Diagnostic reasoning is frequently discussed
-
psnet.ahrq.gov/node/37020/psn-pdf
July 24, 2008 - A previous
WebM&M commentary discussed a tubing error that led to administration of the wrong gas.
-
psnet.ahrq.gov/node/856592/psn-pdf
January 01, 2024 - Risk assessments and categorization (e.g., high- or low-risk) were discussed in
conjunction with strategies
-
psnet.ahrq.gov/node/865523/psn-pdf
April 10, 2024 - Perceived safety in the context of ethics, economics, transparency, and more are also discussed.
-
psnet.ahrq.gov/node/865723/psn-pdf
June 18, 2024 - Presenters discussed the survey results, how SOPS
resources were used, and their focus on initiatives
-
psnet.ahrq.gov/node/865971/psn-pdf
May 29, 2024 - Strategies to address
challenges are discussed.
-
psnet.ahrq.gov/node/36395/psn-pdf
May 04, 2015 - https://psnet.ahrq.gov/issue/introduction-improved-fda-prescription-drug-labeling
This teleconference discussed
-
psnet.ahrq.gov/node/866938/psn-pdf
October 09, 2024 - patients-role-diagnostic-safety-and-excellence-passive-reception-towards-co-
design
While patient involvement in health care is often discussed
-
psnet.ahrq.gov/node/837668/psn-pdf
July 13, 2022 - Subcategories and contributing factors are also discussed.
-
psnet.ahrq.gov/node/48105/psn-pdf
July 10, 2019 - A
WebM&M commentary discussed an incident involving a medical student who failed to report an error.
-
psnet.ahrq.gov/node/72818/psn-pdf
March 10, 2021 - community pharmacies in England, the authors found that polypharmacy was a
pervasive problem but rarely discussed
-
psnet.ahrq.gov/node/844794/psn-pdf
January 01, 2020 - The strategies discussed center on the importance of organizational communication to
patients, navigating